Cocrystal Pharma COCP
Cocrystal Pharma: quarterly report for the quarter ended Mar 31, 2023
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001493152-23-016927
- Document
- 10-Q
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Citius Pharmaceuticals CTXR public float $11M, Mar 31, 2025, over 18 months old
- Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
- Palisade Bio PALI public float $11M, Jun 30, 2025
- Cypherpunk Technologies CYPH public float $12M, Jun 30, 2025
- Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025